Pfizer (NYSE:PFE)‘s stock had its “buy” rating reiterated by investment analysts at TheStreet in a note issued to investors on Monday. Pfizer Inc. (NYSE:PFE) stock opened at $30.99 in last session, and closed at $30.65, while the day range of PFE stock is $30.58 – $31.18. The stock showed a positive weekly performance of 1.79%.
Merck and Co Inc. (NYSE:MRK) is advancing its push into cancer medicine, announcing three collaborations that will investigate combining its experimental drug MK-3475 with therapies developed by rival drugmakers. Merck & Co., Inc. (NYSE:MRK) stock opened at $54.28, in last session and closed at $53.53, by gaining 0.04%. The 52 week range of MRK is $40.83 – $55.20. Company’s market capitalization is $156.66billion.
Gilead Sciences Inc., (NASDAQ:GILD) the world’s largest maker of HIV medicines, has reported profit that beat the forecasts of analysts. Gilead Sciences, Inc. (NASDAQ:GILD) stock decreased -4.72% and finished the last session at $78.15. The EPS of the stock remained 1.55. Company’s market capitalization is $119.83billion.
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA)’s shares jumped 2% to $7.14 in the pre-market hour. Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) stock opened the session at $7.02, and closed the session at $7.10. The 52 week range of the ARIA stock remained $2.15 – $23.00 and the day range was $7.02 – $7.31.
Leave a Reply